Emergent BioSolutions Inc (EBS)
8.97
+0.20
(+2.28%)
USD |
NYSE |
Nov 05, 16:00
8.97
0.00 (0.00%)
After-Hours: 16:11
Emergent BioSolutions Cash from Operations (Quarterly): 47.50M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 47.50M |
| March 31, 2024 | -62.60M |
| December 31, 2023 | 32.10M |
| September 30, 2023 | 60.00M |
| June 30, 2023 | -114.40M |
| March 31, 2023 | -184.00M |
| December 31, 2022 | 92.80M |
| September 30, 2022 | -74.00M |
| June 30, 2022 | -15.60M |
| March 31, 2022 | -37.30M |
| December 31, 2021 | 328.10M |
| September 30, 2021 | 16.70M |
| June 30, 2021 | -29.70M |
| March 31, 2021 | 5.10M |
| December 31, 2020 | 246.00M |
| September 30, 2020 | 105.20M |
| June 30, 2020 | 127.90M |
| March 31, 2020 | 57.80M |
| December 31, 2019 | 122.10M |
| September 30, 2019 | -3.10M |
| June 30, 2019 | -35.80M |
| March 31, 2019 | 104.80M |
| December 31, 2018 | -165.80M |
| September 30, 2018 | 174.00M |
| June 30, 2018 | 34.60M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.00M |
| December 31, 2017 | 77.49M |
| September 30, 2017 | 34.94M |
| June 30, 2017 | 54.00M |
| March 31, 2017 | 41.67M |
| December 31, 2016 | -12.65M |
| September 30, 2016 | 27.08M |
| June 30, 2016 | -1.996M |
| March 31, 2016 | 42.17M |
| December 31, 2015 | 1.128M |
| September 30, 2015 | 104.76M |
| June 30, 2015 | 2.503M |
| March 31, 2015 | -65.87M |
| December 31, 2014 | 51.82M |
| September 30, 2014 | 78.92M |
| June 30, 2014 | 10.82M |
| March 31, 2014 | -29.24M |
| December 31, 2013 | 8.641M |
| September 30, 2013 | 60.12M |
| June 30, 2013 | 32.83M |
| March 31, 2013 | -4.626M |
| December 31, 2012 | -39.02M |
| September 30, 2012 | 46.48M |
| June 30, 2012 | 18.34M |
| March 31, 2012 | 13.84M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-184.00M
Minimum
Mar 2023
328.10M
Maximum
Dec 2021
38.09M
Average
32.10M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Geovax Labs Inc | -1.941M |
| Tonix Pharmaceuticals Holding Corp | -9.919M |
| Abbott Laboratories | 2.705B |
| SIGA Technologies Inc | 5.953M |
| Chimerix Inc | -17.68M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.60M |
| Cash from Financing (Quarterly) | -50.90M |
| Free Cash Flow | 37.60M |
| Free Cash Flow Per Share (Quarterly) | 0.8156 |
| Free Cash Flow to Equity (Quarterly) | 86.60M |
| Free Cash Flow to Firm (Quarterly) | 67.66M |
| Free Cash Flow Yield | 8.03% |